2.74
+0.09(+3.40%)
Currency In USD
| Previous Close | 2.65 |
| Open | 2.65 |
| Day High | 2.75 |
| Day Low | 2.55 |
| 52-Week High | 8.54 |
| 52-Week Low | 1.99 |
| Volume | 323,538 |
| Average Volume | 279,831 |
| Market Cap | 103.07M |
| PE | -3.11 |
| EPS | -0.88 |
| Moving Average 50 Days | 4.92 |
| Moving Average 200 Days | 3.84 |
| Change | 0.09 |
If you invested $1000 in Genelux Corporation (GNLX) since IPO date, it would be worth $445.53 as of January 14, 2026 at a share price of $2.74. Whereas If you bought $1000 worth of Genelux Corporation (GNLX) shares 2 years ago, it would be worth $216.77 as of January 14, 2026 at a share price of $2.74.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners
GlobeNewswire Inc.
Jan 12, 2026 9:00 PM GMT
WESTLAKE VILLAGE, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board; Matt Pulisic, Chief Finan
Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock
GlobeNewswire Inc.
Jan 08, 2026 2:13 PM GMT
WESTLAKE VILLAGE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation (“Genelux”) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today announced the pricing of an underwritten public offering of 6,666,667 shares of its com
Genelux Corporation Announces Proposed Public Offering of Common Stock
GlobeNewswire Inc.
Jan 07, 2026 9:01 PM GMT
WESTLAKE VILLAGE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation (“Genelux”) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today announced that it has commenced a proposed underwritten public offering of its common s